2020
DOI: 10.1016/j.ejca.2020.02.018
|View full text |Cite
|
Sign up to set email alerts
|

Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial

Abstract: Meeting presentation: The results of this study were presented at the ASCO 2017 annual meeting in Chicago, USA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
60
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(62 citation statements)
references
References 35 publications
2
60
0
Order By: Relevance
“…Particularly, chemotherapy and radiotherapy were major factors that can develop severe fatigue [ 118 , 119 ]. Red ginseng can moderate chemotherapy-induced fatigue in colorectal cancer patients, especially older and female patients [ 105 ]. Red ginseng can significantly reduce BFI scores over 8 weeks and 16 weeks.…”
Section: Anti-fatigue Effect In the Clinical Settingmentioning
confidence: 99%
See 1 more Smart Citation
“…Particularly, chemotherapy and radiotherapy were major factors that can develop severe fatigue [ 118 , 119 ]. Red ginseng can moderate chemotherapy-induced fatigue in colorectal cancer patients, especially older and female patients [ 105 ]. Red ginseng can significantly reduce BFI scores over 8 weeks and 16 weeks.…”
Section: Anti-fatigue Effect In the Clinical Settingmentioning
confidence: 99%
“…Reviewing all the studies targeted on diseases-related fatigue, P. ginseng was an effective supplementation in clinical treating diseases-related fatigue. For example, red ginseng can significantly improve mood, relations with others, walking ability and enjoyment of life in colorectal cancer patients with chemotherapy [ 105 ]. Oral ginseng also can improve quality of life, such as muscular pain, degree of happiness, appetite and sleep quality, as well as mood condition in nonmetastatic cancer patients [ 104 ].…”
Section: Anti-fatigue Effect In the Clinical Settingmentioning
confidence: 99%
“…Although the cause of CRF is obvious, there is currently no effective management or prevention strategy available [2]. Nonpharmaceutical treatments have poor compliance and long-term treatment cycles, while drug-based treatments often cause insomnia, palpitations, anxiety, anorexia, and metabolic abnormalities, as well as a series of adverse side effects that can seriously affect the patient's quality of life [4,6,7]. Thus, novel and safe management strategies for CRF are urgently required.…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies on the pharmacological efficacy of KRG have been published through in vitro, in vivo, and clinical trials. In a study by Kim et al [ 5 ], patients with colorectal cancer who received mFOLFOX-6 chemotherapy were randomly administered either KRG 2000 mg/day or placebo for 16 weeks. Compared to the placebo group, the KRG group had reduced cancer-related fatigue [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…In a study by Kim et al [ 5 ], patients with colorectal cancer who received mFOLFOX-6 chemotherapy were randomly administered either KRG 2000 mg/day or placebo for 16 weeks. Compared to the placebo group, the KRG group had reduced cancer-related fatigue [ 5 ]. Moreover, 12-week KRG administration to menopausal women significantly increased superoxide dismutase (SOD) activity [ 6 ].…”
Section: Introductionmentioning
confidence: 99%